<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">ophthalmology</journal-id><journal-title-group><journal-title xml:lang="ru">Офтальмология</journal-title><trans-title-group xml:lang="en"><trans-title>Ophthalmology in Russia</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1816-5095</issn><issn pub-type="epub">2500-0845</issn><publisher><publisher-name>Ophthalmology</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.18008/1816-5095-2023-4-787-798</article-id><article-id custom-type="elpub" pub-id-type="custom">ophthalmology-2252</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КЛИНИЧЕСКИЙ СЛУЧАЙ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CASE REPORT</subject></subj-group></article-categories><title-group><article-title>Клинико-морфологический анализ осложнений эндотелиальной кератопластики (клинические наблюдения)</article-title><trans-title-group xml:lang="en"><trans-title>Clinicopathologic Analyses of Failed Endothelial Keratoplasty (the Clinical Cases)</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4043-456X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Юсеф</surname><given-names>Ю. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Yusef</surname><given-names>Yu. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Юсеф Наим Юсеф доктор медицинских наук, профессор, директор ФГБНУ «НИИГБ им. М.М. Краснова» ул. Россолимо, 11а, б, Москва, 119021</p><p>ул. Трубецкая, 8, стр. 2, Москва, 119991</p></bio><bio xml:lang="en"><p>Yusef Naim Yusef, MD, Professor, director</p><p>Rossolimo str., 11A, B, Moscow, 119021;</p><p>Trubetskaya str., 8/2. Moscow, 119991</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7198-4498</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Фисенко</surname><given-names>Н. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Fisenko</surname><given-names>N. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Фисенко Наталья Владимировна кандидат медицинских наук, старший научный сотрудник отдела патологии оптических сред глаза</p><p>ул. Россолимо, 11а, б, Москва, 119021</p></bio><bio xml:lang="en"><p>Fisenko Natalia V. PhD, senior researcher of Eye optical system pathology department</p><p>Rossolimo str., 11A, B, Moscow, 119021</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6946-6146</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Демура</surname><given-names>Т. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Demura</surname><given-names>T. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Демура Татьяна Александровна доктор медицинских наук, директор Института клинической морфологии и цифровой патологии</p><p>ул. Трубецкая, 8, стр. 2, Москва, 119991</p></bio><bio xml:lang="en"><p>Demura Tatiana A. MD, director of Institute of clinical morphology and digital pathology</p><p>Trubetskaya str., 8/2. Moscow, 119991</p></bio><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1056-4331</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Осипян</surname><given-names>Г. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Osipyan</surname><given-names>G. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Осипян Григорий Альбертович доктор медицинских наук, заведующий отделом патологии оптических сред глаза</p><p>ул. Россолимо, 11а, б, Москва, 119021</p></bio><bio xml:lang="en"><p>Osipyan Grigoriy A. MD, head of Eye optical system pathology department</p><p>Rossolimo str., 11A, B, Moscow, 119021</p></bio><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБНУ «Научно-исследовательский институт глазных болезней имени М.М. Краснова»;&#13;
ФГАОУ ВО «Первый Московский государственный медицинский университет им. И.М. Сеченова» Министерства здравоохранения Российской Федерации (Сеченовский Университет)</institution><country>Россия</country></aff><aff xml:lang="en"><institution>M.M. Krasnov Research Institute of Eye Diseases;&#13;
I.M. Sechenov First Moscow State Medical University (Sechenov University)</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФГБНУ «Научно-исследовательский институт глазных болезней имени М.М. Краснова»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>M.M. Krasnov Research Institute of Eye Diseases</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>ФГАОУ ВО «Первый Московский государственный медицинский университет им. И.М. Сеченова» Министерства здравоохранения Российской Федерации (Сеченовский Университет)</institution><country>Россия</country></aff><aff xml:lang="en"><institution>I.M. Sechenov First Moscow State Medical University (Sechenov University)</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2023</year></pub-date><pub-date pub-type="epub"><day>28</day><month>12</month><year>2023</year></pub-date><volume>20</volume><issue>4</issue><fpage>787</fpage><lpage>798</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Юсеф Ю.Н., Фисенко Н.В., Демура Т.А., Осипян Г.А., 2023</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="ru">Юсеф Ю.Н., Фисенко Н.В., Демура Т.А., Осипян Г.А.</copyright-holder><copyright-holder xml:lang="en">Yusef Y.N., Fisenko N.V., Demura T.A., Osipyan G.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.ophthalmojournal.com/opht/article/view/2252">https://www.ophthalmojournal.com/opht/article/view/2252</self-uri><abstract><p>Цель: осуществить клинико-морфологический анализ осложнений кератопластики, выполненной при эндотелиальной дисфункции роговицы различного генеза на примере клинических наблюдений. Пациенты и методы. В исследование включены 11 пациентов (11 глаз) с рецидивом буллезной кератопатии (БК), возникшим в разные сроки после эндотелиальной кератопластики. 1-я группа представлена 4 пациентами, которым выполнили повторную заднюю автоматизированную послойную кератопластику (ЗАПК). 2-ю группу составили 7 пациентов, которым была проведена сквозная кератопластика (СКП) после трансплантации десцеметовой мембраны с эндотелием (ТДМ). Всем больным выполнена оптическая когерентная томография (ОКТ) роговицы (RTvue-100, Optovue, США). При кератопластике получены образцы внутриглазной жидкости (ВГЖ) для проведения мультиплексного анализа концентрации биологически активных эндогенных факторов, а также роговичная ткань для гистологического исследования (окрашивание гематоксилином и эозином) и ИГХ-анализа экспрессии панцитокератина, виментина, коллагена III типа. Результаты. Анализ клинических наблюдений показал, что рецидив БК проявляется повышением провоспалительных факторов во ВГЖ, отеком, неоваскуляризацией и ремоделированием роговичной ткани с исходом в фиброз. Глаукома является фактором риска развития несостоятельности трансплантата после ЗАПК и ТДМ вследствие персистенции локального воспаления. Среди причин рецидива БК в представленных случаях выявлены неправильное расположение трансплантата (периферическая и центральная отслойка, адаптация эндотелиальной поверхностью к строме пациента), неоднократная пневмотампонада передней камеры, а также генетически детерминированные изменения трансплантата. Заключение. Локальный хронический воспалительный процесс при рецидиве БК проявляется структурными изменениями роговицы, что является показанием к проведению рекератопластики. Тип операции — ТДМ/ЗАПК или СКП — следует определять исходя из биомикроскопической и ОКТ-картины роговицы. С учетом высокого риска развития локальной иммунной реакции (особенно в случае неоднократной кератопластики) необходимо назначение в более высоких дозах глюкокортикостероидных лекарственных средств, в ряде случаев — цитотоксических препаратов.</p></abstract><trans-abstract xml:lang="en"><p>Purpose: To evaluate the clinicopathologic features of failed endothelial keratoplasty. Methods. In this study 11 patients (11 eyes) with recurrence of bullous keratopathy (BK) were included. Group 1 consisted of 4 patients who underwent repeat Descemet Stripping Automated Endothelial Keratoplasty (DSAEK), group 2 included 7 patients who underwent penetrating keratoplasty (PK) after failed Descemet Membrane Endothelial Keratoplasty (DMEK). Preoperative anterior segment optical coherence tomography (OCT), RTVue-100, Optovue, USA, was performed. Intraoperatively aqueous humour (AqH) samples were collected for multiplex cytokine analysis. During keratoplasty failed grafts/corneal buttons were obtained and then investigated histologically (hematoxylin/eosin staining, primary antibodies to pancytokeratin, vimentin, collagen III). Results. Recurrence of BK in all clinical cases manifests by the increase of inflammatory factors in AqH, corneal edema, neovascularization and remodeling to fibrosis. Glaucoma may induce DMEK/ DSAEK graft failure due to chronic local inflammation. In the clinical cases recurrence of BK was caused by peripheral and central graft detachment, rebubbling, graft upside-down orientation and donor corneal genetic disorders. Conclusions. Chronic local inflammation (including corneal morphological changes) in patients with BK recurrence is an indication for reoperation. The modification of keratoplasty — DMEK/DSAEK/PK — is determined according to slit-lamp and OCT images of the cornea. High-level risk of immune reaction (especially in cases of three and more times repeated keratolasty) is the reason for systemic corticosteroid and, sometimes, cytostatic therapy.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>буллезная кератопатия</kwd><kwd>эндотелиальная дисфункция роговицы</kwd><kwd>отслойка трансплантата</kwd><kwd>несостоятельность трансплантата</kwd><kwd>трансплантация десцеметовой мембраны с эндотелием</kwd><kwd>задняя автоматизированная послойная кератопластика</kwd></kwd-group><kwd-group xml:lang="en"><kwd>bullous keratopathy</kwd><kwd>corneal endothelial dysfunction</kwd><kwd>graft detachment</kwd><kwd>graft failure</kwd><kwd>Descemet membrane endothelial keratoplasty</kwd><kwd>Descemet stripping automated endothelial keratoplasty</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Feizi S. Corneal endothelial cell dysfunction: etiologies and management. Ther Adv Ophthalmol. 2018 Dec 7;10:2515841418815802 doi: 10.1177/2515841418815802.</mixed-citation><mixed-citation xml:lang="en">Feizi S. Corneal endothelial cell dysfunction: etiologies and management. Ther Adv Ophthalmol. 2018 Dec 7;10:2515841418815802 doi: 10.1177/2515841418815802.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Price MO, Mehta JS, Jurkunas UV, Price FW Jr. Corneal endothelial dysfunction: Evolving understanding and treatment options. Prog Retin Eye Res. 2021 May;82:100904. doi: 10.1016/j.preteyeres.2020.100904.</mixed-citation><mixed-citation xml:lang="en">Price MO, Mehta JS, Jurkunas UV, Price FW Jr. Corneal endothelial dysfunction: Evolving understanding and treatment options. Prog Retin Eye Res. 2021 May;82:100904. doi: 10.1016/j.preteyeres.2020.100904.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Труфанов С.В., Саловарова Е.П. Дисфункция эндотелиального слоя роговицы: этиопатогенез и современные подходы к лечению. Клиническая офтальмология. 2019;19(2):116–119. doi: 10.32364/2311-7729-2019-19-2-116-119.</mixed-citation><mixed-citation xml:lang="en">Trufanov SV, Salovarova EP. Corneal endothelial dysfunction: etiology, pathogenesis, and current treatment approaches. Russian Journal of Clinical Ophthalmology. 2019;19(2):116–119 (In Russ.). doi: 10.1016/j.preteyeres.2020.100904.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Ong HS, Ang M, Mehta JS. Evolution of therapies for the corneal endothelium: past, present and future approaches. Br J Ophthalmol. 2021 Apr;105(4):454–467. doi: 10.1136/bjophthalmol-2020-316149.</mixed-citation><mixed-citation xml:lang="en">Ong HS, Ang M, Mehta JS. Evolution of therapies for the corneal endothelium: past, present and future approaches. Br J Ophthalmol. 2021 Apr;105(4):454–467. doi: 10.1136/bjophthalmol-2020-316149.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Price MO, Gupta P, Lass J, Price FW Jr. EK (DLEK, DSEK, DMEK): New Frontier in Cornea Surgery. Annu Rev Vis Sci. 2017 Sep 15;3:69–90. doi: 10.1146/annurevvision-102016-061400.</mixed-citation><mixed-citation xml:lang="en">Price MO, Gupta P, Lass J, Price FW Jr. EK (DLEK, DSEK, DMEK): New Frontier in Cornea Surgery. Annu Rev Vis Sci. 2017 Sep 15;3:69–90. doi: 10.1146/annurevvision-102016-061400.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Малюгин Б.Э., Шилова Н.Ф., Анисимова Н.С., Антонова O.П. Трансплантация эндотелия и десцеметовой мембраны. Вестник офтальмологии. 2019;135(1):98–103. doi: 10.17116/oftalma201913501198.</mixed-citation><mixed-citation xml:lang="en">Maliugin BÉ, Shilova NF, Anisimova NS, Antonova OP. Transplantation of endo thelium and Descemet’s membrane. Vestnik Oftalmologii. 2019;135(1):98–103 (In Russ.). doi: 10.17116/oftalma201913501198.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Hemaya M, Hemaya M, Habeeb A. Evaluating Keratoplasty for Fuchs’ Endothelial Corneal Dystrophy: A Literature Review. Cureus. 2023 Jan 11;15(1):e33639. doi: 10.7759/cureus.33639.</mixed-citation><mixed-citation xml:lang="en">Hemaya M, Hemaya M, Habeeb A. Evaluating Keratoplasty for Fuchs’ Endothelial Corneal Dystrophy: A Literature Review. Cureus. 2023 Jan 11;15(1):e33639. doi: 10.7759/cureus.33639.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Müller TM, Verdijk RM, Lavy I, Bruinsma M, Parker J, Binder PS, Melles GR. Histopathologic Features of Descemet Membrane Endothelial Keratoplasty Graft Remnants, Folds, and Detachments. Ophthalmology. 2016 Dec;123(12):2489–2497. doi: 10.1016/j.ophtha.2016.08.014.</mixed-citation><mixed-citation xml:lang="en">Müller TM, Verdijk RM, Lavy I, Bruinsma M, Parker J, Binder PS, Melles GR. Histopathologic Features of Descemet Membrane Endothelial Keratoplasty Graft Remnants, Folds, and Detachments. Ophthalmology. 2016 Dec;123(12):2489–2497. doi: 10.1016/j.ophtha.2016.08.014.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Фисенко Н.В., Демура Т.А., Труфанов С.В., Воронин Г.В. Морфологические особенности удаленной при эндотелиальной кератопластике десцеметовой мембраны (клинические наблюдения). Вестник офтальмологии. 2022;138(2):81–86. doi: 10.17116/oftalma202213802181.</mixed-citation><mixed-citation xml:lang="en">Fisenko NV, Demura TA, Trufanov SV, Voronin GV. Morphological characteristics of Descemet’s membrane removed during endothelial keratoplasty (case study). Annals of Ophthalmology. 2022;138(2):81–86 (In Russ.). doi: 10.17116/oftalma202213802181.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Trindade BLC, Eliazar GC. Descemet membrane endothelial keratoplasty (DMEK): an update on safety, efficacy and patient selection. Clin Ophthalmol. 2019 Aug 16;13:1549–1557. doi: 10.2147/OPTH.S178473.</mixed-citation><mixed-citation xml:lang="en">Trindade BLC, Eliazar GC. Descemet membrane endothelial keratoplasty (DMEK): an update on safety, efficacy and patient selection. Clin Ophthalmol. 2019 Aug 16;13:1549–1557. doi: 10.2147/OPTH.S178473.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Gómez-Benlloch A, Montesel A, Pareja-Aricò L, Mingo-Botín D, Michael R, Barraquer RI, Alió J. Causes of corneal transplant failure: a multicentric study. Acta Ophthalmol. 2021 Sep;99(6):e922–e928. doi: 10.1111/aos.14708.</mixed-citation><mixed-citation xml:lang="en">Gómez-Benlloch A, Montesel A, Pareja-Aricò L, Mingo-Botín D, Michael R, Barraquer RI, Alió J. Causes of corneal transplant failure: a multicentric study. Acta Ophthalmol. 2021 Sep;99(6):e922–e928. doi: 10.1111/aos.14708.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Hos D, Matthaei M, Bock F, Maruyama K, Notara M, Clahsen T, Hou Y, Le VNH, Salabarria AC, Horstmann J, Bachmann BO, Cursiefen C. Immune reactions after modern lamellar (DALK, DSAEK, DMEK) versus conventional penetrating corneal transplantation. Prog Retin Eye Res. 2019 Nov;73:100768. doi: 10.1016/j.preteyeres.2019.07.001.</mixed-citation><mixed-citation xml:lang="en">Hos D, Matthaei M, Bock F, Maruyama K, Notara M, Clahsen T, Hou Y, Le VNH, Salabarria AC, Horstmann J, Bachmann BO, Cursiefen C. Immune reactions after modern lamellar (DALK, DSAEK, DMEK) versus conventional penetrating corneal transplantation. Prog Retin Eye Res. 2019 Nov;73:100768. doi: 10.1016/j.preteyeres.2019.07.001.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Фисенко Н.В., Демура Т.А., Осипян Г.А., Аветисов К.С. Оценка влияния сопутствующей глаукомы на уровень биологически активных эндогенных веществ во внутриглазной жидкости при эндотелиальной дистрофии роговицы Фукса и вторичной буллезной кератопатии. Офтальмология. 2023;20(2):253–259. doi: 10.18008/1816-5095-2023-2-253-259.</mixed-citation><mixed-citation xml:lang="en">Fisenko NV, Demura TA, Osipyan GA, Avetisov KS. The Influence of Glaucoma as a Comorbidity on Cytokine Expression in Aqueous Humor of Patients with Fuchs Endothelial Corneal Dystrophy and Bullous Keratopathy. Ophthalmology in Russia. 2023;20(2):253–259 (In Russ.). doi: 10.18008/1816-5095-2023-2-253-259.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Schrittenlocher S, Grass C, Dietlein T, Lappas A, Matthaei M, Cursiefen C, Bachmann B. Graft survival of Descemet membrane endothelial keratoplasty (DMEK) in corneal endothelial decompensation after glaucoma surgery. Graefes Arch Clin Exp Ophthalmol. 2022 May;260(5):1573–1582. doi: 10.1007/s00417-021-05506-4.</mixed-citation><mixed-citation xml:lang="en">Schrittenlocher S, Grass C, Dietlein T, Lappas A, Matthaei M, Cursiefen C, Bachmann B. Graft survival of Descemet membrane endothelial keratoplasty (DMEK) in corneal endothelial decompensation after glaucoma surgery. Graefes Arch Clin Exp Ophthalmol. 2022 May;260(5):1573–1582. doi: 10.1007/s00417-021-05506-4.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Yagi-Yaguchi Y, Yamaguchi T, Higa K, Suzuki T, Aketa N, Dogru M, Satake Y, Shimazaki J. Association between corneal endothelial cell densities and elevated cytokine levels in the aqueous humor. Sci Rep. 2017 Oct 19;7(1):13603. doi: 10.1038/s41598-017-14131-3.</mixed-citation><mixed-citation xml:lang="en">Yagi-Yaguchi Y, Yamaguchi T, Higa K, Suzuki T, Aketa N, Dogru M, Satake Y, Shimazaki J. Association between corneal endothelial cell densities and elevated cytokine levels in the aqueous humor. Sci Rep. 2017 Oct 19;7(1):13603. doi: 10.1038/s41598-017-14131-3.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Yazu H, Yamaguchi T, Aketa N, Higa K, Suzuki T, Yagi-Yaguchi Y, Satake Y, Abe T, Tsubota K, Shimazaki J. Preoperative Aqueous Cytokine Levels are Associated With Endothelial Cell Loss After Descemet’s Stripping Automated Endothelial Keratoplasty. Invest Ophthalmol Vis Sci. 2018 Feb 1;59(2):612–620. doi: 10.1167/iovs.17-23049.</mixed-citation><mixed-citation xml:lang="en">Yazu H, Yamaguchi T, Aketa N, Higa K, Suzuki T, Yagi-Yaguchi Y, Satake Y, Abe T, Tsubota K, Shimazaki J. Preoperative Aqueous Cytokine Levels are Associated With Endothelial Cell Loss After Descemet’s Stripping Automated Endothelial Keratoplasty. Invest Ophthalmol Vis Sci. 2018 Feb 1;59(2):612–620. doi: 10.1167/iovs.17-23049.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Yamaguchi T, Higa K, Tsubota K, Shimazaki J. Elevation of preoperative recipient aqueous cytokine levels in eyes with primary graft failure after corneal transplantation. Mol Vis. 2018 Sep 13;24:613–620.</mixed-citation><mixed-citation xml:lang="en">Yamaguchi T, Higa K, Tsubota K, Shimazaki J. Elevation of preoperative recipient aqueous cytokine levels in eyes with primary graft failure after corneal transplantation. Mol Vis. 2018 Sep 13;24:613–620.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Todokoro D, Miyakubo T, Makimura K, Tamura T, Komori A, Akiyama H. Fungal Keratitis Caused by Talaromyces coalescens: A Case Report. Mycopathologia. 2023 Jun;188(3):251–254. doi: 10.1007/s11046-023-00738-w.</mixed-citation><mixed-citation xml:lang="en">Todokoro D, Miyakubo T, Makimura K, Tamura T, Komori A, Akiyama H. Fungal Keratitis Caused by Talaromyces coalescens: A Case Report. Mycopathologia. 2023 Jun;188(3):251–254. doi: 10.1007/s11046-023-00738-w.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Bardan AS, Goweida MB, El Goweini HF, Liu CS. Management of Upside-Down Descemet Membrane Endothelial Keratoplasty: A Case Series. J Curr Ophthalmol. 2020 Apr 30;32(2):142–148. doi: 10.4103/JOCO.JOCO_102_20.</mixed-citation><mixed-citation xml:lang="en">Bardan AS, Goweida MB, El Goweini HF, Liu CS. Management of Upside-Down Descemet Membrane Endothelial Keratoplasty: A Case Series. J Curr Ophthalmol. 2020 Apr 30;32(2):142–148. doi: 10.4103/JOCO.JOCO_102_20.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Parekh M, Leon P, Ruzza A, Borroni D, Ferrari S, Ponzin D, Romano V. Graft detachment and rebubbling rate in Descemet membrane endothelial keratoplasty. Surv Ophthalmol. 2018 Mar-Apr;63(2):245–250. doi: 10.1016/j.survophthal.2017.07.003.</mixed-citation><mixed-citation xml:lang="en">Parekh M, Leon P, Ruzza A, Borroni D, Ferrari S, Ponzin D, Romano V. Graft detachment and rebubbling rate in Descemet membrane endothelial keratoplasty. Surv Ophthalmol. 2018 Mar-Apr;63(2):245–250. doi: 10.1016/j.survophthal.2017.07.003.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Tapley JL, Hill JR, Bauer AJ, Straiko MMW, Straiko MD, Terry MA. Rate of Endothelial Cell Loss and Graft Survival in Descemet Membrane Endothelial Keratoplasty in Eyes Requiring a Rebubble. Cornea. 2023 Aug 1;42(8):934–939. doi: 10.1097/ICO.0000000000003118.</mixed-citation><mixed-citation xml:lang="en">Tapley JL, Hill JR, Bauer AJ, Straiko MMW, Straiko MD, Terry MA. Rate of Endothelial Cell Loss and Graft Survival in Descemet Membrane Endothelial Keratoplasty in Eyes Requiring a Rebubble. Cornea. 2023 Aug 1;42(8):934–939. doi: 10.1097/ICO.0000000000003118.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
